Recommended

'Betrayal': 6 reactions to FDA's approval of generic abortion drug

3. Kristan Hawkins

Students for Life of America and Students for Life Action President Kristan Hawkins advocates for defunding Planned Parenthood during a March 2025 rally in front of the U.S. Capitol Building.
Students for Life of America and Students for Life Action President Kristan Hawkins advocates for defunding Planned Parenthood during a March 2025 rally in front of the U.S. Capitol Building. | Courtesy of Students for Life of America

Students for Life of America and Students for Life Action President Kristan Hawkins condemned the FDA’s approval of a new generic version of the abortion drug mifepristone, calling the decision “a stain on the Trump presidency.” 

“The Trump Administration’s approval of a new and deadly generic version of Mifepristone, without doing anything to protect mothers from abusers, women from reckless distribution leading to injury, infertility, and even death, or the environment from abortion water pollution, represents a true failure,” Hawkins stated in a Thursday X post

“More babies will die; More women will be harmed; and More Americans [will be] exposed to Abortion Water Pollution as a direct result of this unfathomable decision,” she warned.

Samantha Kamman is a reporter for The Christian Post. She can be reached at: samantha.kamman@christianpost.com. Follow her on Twitter: @Samantha_Kamman

You’ve readarticles in the last 30 days.

Was this article helpful?

Help keep The Christian Post free for everyone.

Our work is made possible by the generosity of supporters like you. Your contributions empower us to continue breaking stories that matter, providing clarity from a biblical worldview, and standing for truth in an era of competing narratives.

By making a recurring donation or a one-time donation of any amount, you’re helping to keep CP’s articles free and accessible for everyone.

We’re sorry to hear that.

Hope you’ll give us another try and check out some other articles. Return to homepage.

Most Popular